$NBIO “This is a significant accomplishment in the advancement of our Biologic asset and in our mission to help future patients in their battle against this terrible disease,” Nascent CEO, Sean Carrick.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.